Search Science Hub

Science Hub is Novo Nordisk’s one-stop portal for all our scientific publications and clinical trials, congress materials and medical updates. Sign up to gain full access.

Welcome to Novo Nordisk Science Hub

Are you a healthcare professional?

EASL 2026 27 - 30 May 2026

Efficacy and safety of semaglutide 2.4 mg in the Japanese subgroup of the ESSENCE study

Authors :

Atsushi Nakajima^1,2; Takeshi Okanoue³; Yoichi Hiasa⁴; Hirokazu Takahashi⁵; Adel Belloum^6*; Nobuyoshi Kosaka⁷; Tomoyuki Nishida⁷; Arun J. Sanyal⁸

Affiliations

View Details Hide Details

Download .PDF

Keywords

MASH

Congress poster

GLP-1 RA

Semaglutide

PHASE 3 (RCT)